Pancreatic cancer is one of the biggest challenges oncology faces. It is on the rise, possibly also among young people, and its survival rate remains very low – less than 5% of patients live for five years after diagnosis. It is often detected in the advanced stage, when the tumour is no longer operable. The … Continue reading The latest research on the most lethal cancer: from an ‘app’ to estimate personalised risk to new, more effective drugs